| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ULTRASMEDBIO.2019.11.007 |
| P698 | PubMed publication ID | 31899040 |
| P50 | author | Beat A Kaufmann | Q83298510 |
| Jonathan R Lindner | Q89706631 | ||
| P2093 | author name string | Sayan Chowdhury | |
| Lotfi Abou-Elkacem | |||
| Alexandra Kosareva | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis | Q27339951 | ||
| Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles | Q28138819 | ||
| The role of selectins in inflammation and disease | Q28182332 | ||
| Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion | Q28263850 | ||
| Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice | Q28267720 | ||
| Adhesion receptors of the immune system | Q29616393 | ||
| Targeted ultrasound contrast agents: In vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx | Q30047197 | ||
| Echocardiographic Ischemic Memory Imaging Through Complement-Mediated Vascular Adhesion of Phosphatidylserine-Containing Microbubbles | Q30276554 | ||
| Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes | Q30304696 | ||
| Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles | Q30305905 | ||
| Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes | Q30306464 | ||
| Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin | Q30308172 | ||
| Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography | Q30309235 | ||
| Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration | Q30309358 | ||
| Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement | Q30309873 | ||
| Molecular imaging with contrast ultrasound and targeted microbubbles | Q30312262 | ||
| In vitro characterization of liposomes and Optison by acoustic scattering at 3.5 MHz. | Q30379889 | ||
| Ischemic memory imaging in nonhuman primates with echocardiographic molecular imaging of selectin expression | Q30407883 | ||
| First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study | Q38931014 | ||
| Acoustic Behavior of a Reactivated, Commercially Available Ultrasound Contrast Agent | Q39113493 | ||
| Platelets and von Willebrand factor in atherogenesis | Q39125083 | ||
| Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody | Q39991117 | ||
| Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study | Q40664994 | ||
| Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents | Q41066998 | ||
| A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation | Q41824616 | ||
| A prospective natural-history study of coronary atherosclerosis | Q41983924 | ||
| Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. | Q42124769 | ||
| Biodistributions of air-filled albumin microspheres in rats and pigs | Q42835473 | ||
| Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery. | Q30409097 | ||
| Nitric oxide pretreatment enhances atheroma component highlighting in vivo with intercellular adhesion molecule-1-targeted echogenic liposomes | Q30410620 | ||
| Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection | Q30416185 | ||
| Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model | Q30417587 | ||
| Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents | Q30427317 | ||
| Myocardial ischemic memory imaging with molecular echocardiography | Q30432468 | ||
| Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow | Q30433437 | ||
| Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow | Q30433916 | ||
| Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging | Q30435670 | ||
| Recent advances in molecular, multimodal and theranostic ultrasound imaging | Q30436709 | ||
| Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease | Q30439177 | ||
| Factors affecting the endothelial retention of targeted microbubbles: influence of microbubble shell design and cell surface projection of the endothelial target molecule. | Q30442068 | ||
| Molecular imaging of the paracrine proangiogenic effects of progenitor cell therapy in limb ischemia | Q30443135 | ||
| Enhanced targeting of ultrasound contrast agents using acoustic radiation force | Q30443456 | ||
| Noninvasive ultrasound molecular imaging of the effect of statins on endothelial inflammatory phenotype in early atherosclerosis | Q30455730 | ||
| An in vivo evaluation of the effect of repeated administration and clearance of targeted contrast agents on molecular imaging signal enhancement | Q30458183 | ||
| Dysregulated selectin expression and monocyte recruitment during ischemia-related vascular remodeling in diabetes mellitus | Q30461411 | ||
| Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound | Q30463873 | ||
| In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells | Q30466579 | ||
| Formulation and characterization of echogenic lipid-Pluronic nanobubbles | Q30470286 | ||
| Myocardial perfusion characteristics and hemodynamic profile of MRX-115, a venous echocardiographic contrast agent, during acute myocardial infarction | Q30471759 | ||
| Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype | Q30473382 | ||
| Ligand conjugation to bimodal poly(ethylene glycol) brush layers on microbubbles. | Q30474502 | ||
| Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). | Q30474689 | ||
| Molecular ultrasound imaging: current status and future directions | Q30474725 | ||
| Molecular ultrasound assessment of tumor angiogenesis | Q30474770 | ||
| Effect of acoustic power on in vivo molecular imaging with targeted microbubbles: implications for low-mechanical index real-time imaging. | Q30477838 | ||
| Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease | Q30492960 | ||
| Radiation-force assisted targeting facilitates ultrasonic molecular imaging | Q30503010 | ||
| Detection of antecedent myocardial ischemia with multiselectin molecular imaging | Q30559110 | ||
| Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events | Q33151664 | ||
| Engineering novel binding proteins from nonimmunoglobulin domains | Q33224761 | ||
| A new generation of protein display scaffolds for molecular recognition | Q33230194 | ||
| Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agents | Q43824779 | ||
| Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi | Q44190009 | ||
| Leukocyte-targeted myocardial contrast echocardiography can assess the degree of acute allograft rejection in a rat cardiac transplantation model | Q44766904 | ||
| Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. | Q45940724 | ||
| Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. | Q45958600 | ||
| Pharmacokinetics of perfluorobutane following intravenous bolus injection and continuous infusion of sonazoid in healthy volunteers and in patients with reduced pulmonary diffusing capacity | Q46838780 | ||
| Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma | Q47200008 | ||
| Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells | Q47842786 | ||
| Ultrasound molecular imaging of acute cellular cardiac allograft rejection in rat with T-cell-specific nanobubbles | Q47844118 | ||
| Intravascular ultrasound molecular imaging of atheroma components in vivo | Q47972229 | ||
| Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results | Q49774225 | ||
| Ultrasound molecular imaging of acute cardiac transplantation rejection using nanobubbles targeted to T lymphocytes | Q49916739 | ||
| Enhanced detection of thromboemboli with the use of targeted microbubbles. | Q50917658 | ||
| Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. | Q50970470 | ||
| Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. | Q50995366 | ||
| Efficacy of contrast-enhanced US and magnetic microbubbles targeted to vascular cell adhesion molecule-1 for molecular imaging of atherosclerosis. | Q51034923 | ||
| Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. | Q51040468 | ||
| The role of complement in the adherence of microbubbles to dysfunctional arterial endothelium and atherosclerotic plaque. | Q51089649 | ||
| Noninvasive Contrast-Enhanced Ultrasound Molecular Imaging Detects Myocardial Inflammatory Response in Autoimmune Myocarditis. | Q51211011 | ||
| Destruction of contrast microbubbles and the association with inertial cavitation. | Q52541047 | ||
| Left ventricular thrombus enhancement after intravenous injection of echogenic immunoliposomes: studies in a new experimental model. | Q52940334 | ||
| Thrombotic Microangiopathies | Q56286857 | ||
| Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes | Q56386325 | ||
| In Vivo Demonstration of Cancer Molecular Imaging with Ultrasound Radiation Force and Buried-Ligand Microbubbles | Q57425766 | ||
| In Vivo Molecular Imaging Using Low-Boiling-Point Phase-Change Contrast Agents: A Proof of Concept Study | Q57477458 | ||
| The Dynamic Nature of Coronary Artery Lesion Morphology Assessed by Serial Virtual Histology Intravascular Ultrasound Tissue Characterization | Q61651417 | ||
| Fibrin-Targeted Polymerized Shell Microbubbles as Potential Theranostic Agents for Surgical Adhesions | Q61965458 | ||
| A novel site-targeted ultrasonic contrast agent with broad biomedical application | Q71958393 | ||
| Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1 | Q73594062 | ||
| Missed diagnoses of acute coronary syndromes in the emergency room--continuing challenges | Q73689105 | ||
| In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles | Q73884730 | ||
| A physiologic flow chamber model to define intravascular ultrasound enhancement of fibrin using echogenic liposomes | Q77847429 | ||
| Modulating targeted adhesion of an ultrasound contrast agent to dysfunctional endothelium | Q78567192 | ||
| Contrast echocardiography | Q79510358 | ||
| Growth and metastasis of tumor in organ culture | Q79541783 | ||
| Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis | Q80836287 | ||
| Molecular imaging of vascular phenotype in cardiovascular disease: new diagnostic opportunities on the horizon | Q83983757 | ||
| Platelet-targeted microbubbles inhibit re-occlusion after thrombolysis with transcutaneous ultrasound and microbubbles | Q85121166 | ||
| A new drug delivery system for intravenous coronary thrombolysis with thrombus targeting and stealth activity recoverable by ultrasound | Q85467925 | ||
| Cardiac investigation for prognosis in coronary artery disease: where negative is positive | Q87816671 | ||
| Ultrasound Molecular Imaging of Atherosclerosis Using Small-Peptide Targeting Ligands Against Endothelial Markers of Inflammation and Oxidative Stress | Q88083584 | ||
| Ultrasound Molecular Imaging of Atherosclerosis With Nanobodies: Translatable Microbubble Targeting Murine and Human VCAM (Vascular Cell Adhesion Molecule) 1 | Q90614658 | ||
| Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow | Q90667459 | ||
| Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms | Q91044316 | ||
| Myocardial Infarction Produces Sustained Proinflammatory Endothelial Activation in Remote Arteries | Q91111421 | ||
| Noninvasive quantification of intrarenal allograft C4d deposition with targeted ultrasound imaging | Q91256543 | ||
| Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib | Q91258067 | ||
| Assessment of Novel Antioxidant Therapy in Atherosclerosis by Contrast Ultrasound Molecular Imaging | Q91433063 | ||
| Ultrasound Molecular Imaging of Lymphocyte-endothelium Adhesion Cascade in Acute Cellular Rejection of Cardiac Allografts | Q92169115 | ||
| Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells | Q33268457 | ||
| Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target | Q33275939 | ||
| Alternative non-antibody scaffolds for molecular recognition | Q33291380 | ||
| Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura | Q33339170 | ||
| Phase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signatures. | Q33898006 | ||
| Treating the dysfunctional placenta | Q33917113 | ||
| BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis | Q34089383 | ||
| Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging | Q34123101 | ||
| Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging | Q34171483 | ||
| Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging | Q34591102 | ||
| Overexpression of CD90 (Thy-1) in pancreatic adenocarcinoma present in the tumor microenvironment | Q34764691 | ||
| ABC of antithrombotic therapy: An overview of antithrombotic therapy | Q34938373 | ||
| Von Willebrand factor, platelets and endothelial cell interactions | Q35181571 | ||
| Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans | Q35584014 | ||
| Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging | Q35751840 | ||
| CD90 and CD24 Co-Expression Is Associated with Pancreatic Intraepithelial Neoplasias | Q36058936 | ||
| Molecular imaging of thrombus: technology in evolution | Q36135602 | ||
| Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment | Q36477445 | ||
| Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. | Q36617730 | ||
| Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model. | Q36699083 | ||
| Mechanisms of Leukocyte Transendothelial Migration | Q36772665 | ||
| Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model. | Q36871846 | ||
| Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. | Q37133833 | ||
| Liposomes in ultrasonic drug and gene delivery | Q37163645 | ||
| Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. | Q37198592 | ||
| Imaging myocardial metabolism and ischemic memory | Q37222180 | ||
| Diagnostic ultrasound combined with glycoprotein IIb/IIIa-targeted microbubbles improves microvascular recovery after acute coronary thrombotic occlusions | Q37364671 | ||
| Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties | Q37466636 | ||
| Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? | Q37525915 | ||
| Proinflammatory endothelial activation detected by molecular imaging in obese nonhuman primates coincides with onset of insulin resistance and progressively increases with duration of insulin resistance | Q37540095 | ||
| Microbubble-enhanced US in body imaging: what role? | Q37790181 | ||
| Novel echogenic drug-immunoliposomes for drug delivery | Q37867861 | ||
| The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology | Q38069009 | ||
| Interplay between coagulation and vascular inflammation in sickle cell disease | Q38099667 | ||
| Ultrasound molecular imaging of ovarian cancer with CA-125 targeted nanobubble contrast agents | Q38731195 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 479-497 | |
| P577 | publication date | 2019-12-30 | |
| P1433 | published in | Ultrasound in Medicine and Biology | Q2260380 |
| P1476 | title | Seeing the Invisible-Ultrasound Molecular Imaging | |
| P478 | volume | 46 |
Search more.